Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.

Alendronate (ALN), an aminobisphosphonate used in the treatment of osteoporosis, is a potent inhibitor of bone resorption. Its molecular target is still unknown. This study examines the effects of ALN on the activity of osteoclast protein-tyrosine phosphatase (PTP; protein-tyrosine-phosphate phospho...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Proc Natl Acad Sci U S A
Hauptverfasser:	Schmidt, A, Rutledge, S J, Endo, N, Opas, E E, Tanaka, H, Wesolowski, G, Leu, C T, Huang, Z, Ramachandaran, C, Rodan, S B, Rodan, G A
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	National Academy of Sciences 1996
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC39762/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8610169/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.7.3068
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!